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We cloned a cDNA for the rat Ic-opioid receptor from a rat thalamus cDNA library. The deduced amino actd sequence consists of 380 restdues 
with features shared by members of the G protein-coupled receptor family. The specific bmding of [3H]bremazocine to the membrane of COS-7 
cells transfected with the cDNA was displaced by x-specific opioid ligands. but not by p- and S-specific Iigands. Xenopus oocytes injected with the 
m vitro transcribed mRNA responded to opioid hgands with the same subtype spectficity. Northern blot analysis demonstrated that Kc-optoid 
receptor mRNA is expressed in a regionally specific manner in rat brain. 
Opioid receptor; K-Type; Dynorphin A; U50488H 
1. INTRODUCTION 
Opiates produce various pharmacological effects, 
such as analgesia, respiratory depression, catalepsy and 
inhibition of diarrhea, through their specific receptors. 
Dozens of endogenous ligands of these receptors have 
been identified as an opioid peptide family. Pharmacol- 
ogical studies have defined three types of opioid recep- 
tors, i.e., ,u-, S- and K-opioid receptors, which preferen- 
tially bind to morphine, enkephalins and dynorphins, 
respectively [11. 
cDNA library was screened using the clone as a probe 
and we obtained two types of clones homologous to the 
mouse 6-opioid receptor. Here, we show that one of 
these clones encodes rat k--opioid receptor. 
2. MATERIALS AND METHODS 
2.1. Materials 
Recently, the mouse &opioid receptor was cloned by 
expression cloning and shown to belong to the G pro- 
tein-coupled receptor family 121. To understand the 
physiological roles of endogenous opioid peptides and 
mechanisms of action of opiates at a molecular level, 
cloning of other types of opioid receptors is essential. 
Since there is evidence that ,u- and Fc-opioid receptors 
also belong to the G protein-coupled receptor family [3], 
we tried to clone cDNAs for these receptors using the 
PCR technique. RT-PCR was carried out with total 
RNA from rat dorsal root ganglia. This tissue contains 
cell bodies of primary afferent neurons and the release 
of substance P from their terminals was shown to be 
inhibited by morphine [4]. RT-PCR led to a clone which 
had a nucleotide sequence 70.8% homologous to mouse 
&opioid receptor in the corresponding region. A rat 
Dynorphm A (l-17) was purchased from Pepttde Institute, Inc. 
(Minoh. Japan). U50488H was a gift from Upjohn Company (Kala- 
mazoo, USA). DAMGO and DPDPE were from Bachem Feinchemi- 
kalien AG (Bubendorf, Switzerland). Bremazocine was a gift from 
Sandoz A.G. (Base], Switzerland). (-)-[9-‘H(N)]bremazocine (30 Ci/ 
mmol) was obtained from DuPont-New England Nuclear. 
2.2. Molecular cloning of rat oprold receptors 
Correspondence address, M. Satoh, Department of Molecular Phar- 
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Abbrevuztions; PCR, polymerase chain reaction; RT, reverse tran- 
scription; DPDPE, [o-Pen’@Pen’]enkephalin; DAMGO. [D- 
Ala,MePhe4,Gly(ol)5]enkephalin; G protein. GTP bmding protein. 
PCR primers were designed based on the sequence of mouse 6- 
opioid receptor [2]. The sequences of forward and reverse prtmers 
synthestzed are S-GCGC(ATGC)AAGTACTT(ATGC)ATGGAA- 
AC(ATGC)TGG-3’ and 5’-CAGACGATGACGAA(ATGC)ATGT- 
G(ATGC)AT(ATGC)GG-3’, respectively. Total RNA from rat dor- 
sal root ganglia was used for RT-PCR as a template. The procedure 
of RT-PCR was previously described [5]. Briefly, total RNA was 
reverse-transcrtbed wtth MMLV reverse-transcriptase (BRL, Gaith- 
ersburg. USA). An aliquot of the reaction mixture was served as a 
template in 30 cycles of PCR with 0.5 min of denaturation at 95”C, 
0.7 min of annealing at 65°C and 1.5 min of extension at 72°C on a 
Zymoreactor (Atto Corp., Tokyo, Japan). The PCR product was 
electrophoresed on a 1.5% TAE gel. The DNA fragment was extracted 
from the gel and subcloned mto pCR II (Invitrogen, San Diego, USA) 
and sequenced. The sequence of the clone (pR11) was 70.8% homolo- 
gous to the corresponding region of mouse B-opioid receptor cDNA. 
Rat thalamus cDNA was prepared by a random-priming method and 
a cDNA library was constructed using Superscript choice system 
(BRL) and 1 ZAP II phage vector (Stratagene La Jolla, USA). This 
library (1 x lo6 clones) was screened by hybridization with the insert 
of pRl1, Hybridization was carried out at 65°C m 5 x SSC containing 
5 x Denhardt’s solutton and 0.5% SDS, and then filters were washed 
at 65°C in 1 x SSC containing 0.1% SDS. Seven positive clones were 
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isolated and named pMOPRl_5 and pKOPRl,Z based on their se- 
quences and the results of prehminary m situ hybridization histochem- 
Istry 
3.3. (DNA e.upre.won m COS-7 cells and bmdwzg ussq 
The PstIISpeI fragment of pKOPR2 was subcloned into the 
EcoRVNorI site of pcDNAI/Amp (Invttrogen). an eukaryottc expres- 
sion vector, usmg adequate adaptors. The resultant plasmtd DNA 
(pcDNAI/KOPR) was transfected to COS-7 cells by the DEAE-dex- 
tran method [6]. After cultivation for 65 h. the cells were harvested and 
homogenized in the folloamg buffer: 50 mM Tris (pH 7 4). 10 mM 
MgCI,. 1 mM EDTA and 0.25 M sucrose. After centrifugation for IO 
min at 500 x s. the supernatant was centrifuged for 20 min at 
230,000 x g. The pellet was resuspended in 50 mM Tris (pH 7.4) 
containmg 10 mM MgCl, and 1 mM EDTA. Binding experiments 
were carried out with 5 nM [‘Hlbremazocme and various concentra- 
tions of unlabeled subtype-specific opiotd hgands 
2.4. Functiond e.~prcwrott in Xenopus ooq’tes an~clrctropll~stologr~al 
tneumrmtents 
BstXI-linearized pKOPR2 was transcribed in vitro by T7 RNA 
polymerase in the presence of the cap analogue. 7-methyl GpppG, 
usmg an mCAP RNA cappmg kit (Stratagene). The transcript was 
microinjected mto defolhculated Xenopus oocytes. Oocytes were mcu- 
bated at 22°C for I-2 days. Transmembrane current was detected by 
the two-electrode voltage-clamp method [7]. 
2.5. Northern blot una1y.m 
Total RNA was extracted from rat various bram regions with 
RNAzol (Biotecx Laboratories, Inc., Houston, USA), and poly(A)’ 
RNA was purified using an mRNA purification kit (Pharmacia LKB 
Biotechnology, Uppsala, Sweden). Poly(A)’ RNA (4 fig) from each 
bram region was fractionated by electrophoresis on a 1% agarose gel 
containing 6% formaldehyde, transferred to a nylon membrane (BI- 
odyne: Pall. Glen Cove, USA) and baked at 80°C for 3 h. The mem- 
brane was prehybridtzed and then hybridized with the “P-labeled 
antisense RNA probe at 65°C. The membrane was washed twice m 
2 x SSCYO. 1% SDS for 5 min and then twice m 0.1 x SSC/O.l% SDS 
for 30 mm at 65°C and exposed to X-ray film at -80°C using an 
Intensifying screen. 
3. RESULTS AND DISCUSSION 
Preliminary in situ hybridization histochemistry 
using pRl1 as a probe showed that the hybridization 
signal was very prominent in the thalamus. Screening of 
the rat thalamus cDNA library with pR11 gave seven 
positive clones. Sequencing of these clones showed that 
the nucleotide sequences of five clones (pMOPRl-5) 
were the same with that of pR11 in the corresponding 
region, except for one base. This difference was proba- 
bly due to the misincorpolation by Taq DNA polym- 
erase during the PCR procedure. The nucleotide se- 
quences of other two clones (pKOPR1,2) showed 68.5% 
homologies to those of pR11 and mouse &opioid recep- 
tor cDNA in the corresponding region. Because only 
pKOPR2 is thought to contain a full-length coding re- 
gion, further investigation was carried out for pKOPR1 
and 2 in this study. 
Fig. 1 Nucleotide and deduced amino acid sequences of rat K-opioid 
receptor cDNA. The deduced amino acid sequence is shown beneath 
the nucleottde sequence using single letter code Posittons of the puta- 
tive transmembrane segments IIVII are indicated by underhnrs be- 
neath the amino acid sequence. Stars and closed circles show potential 
N-glycosylatton sites in the extracellular regions and potential phos- 
phorylation sites, respectively. 
Fig. 1 shows nucleotide and deduced amino acid se- Kozack nucleotide sequence ACCATGG [8]. The pre- 
quences of pKOPR1 (nucleotides 131-2371) and dicted protein sequence consists of 380 amino acid resi- 
pKOPR2 (nucleotides - 110-l 262). pKOPR2 contained dues with a calculated molecular weight of 42.702. The 
a 1140 bp open reading frame. The nucleotide sequence hydropathicity profile determined by the Kyte and 
surrounding the initiation codon agrees with the Doolittle method [9] and the sequence homology analy- 
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Fig. 2. Dtsplacement of the specific binding of [‘Hlbremazocine to the 
membrane of COS-7 cells transfected with rat K-opiotd receptor 
cDNA. Unlabeled opioid ligands used are as follows; Dynorphm A 
(l-17) to), U50488H (a), DAMGO (w), DPDPE (A). 
sis indicated that it possesses seven hydrophobic seg- 
ments and shares a considerable sequence similarity 
with other G protein-coupled receptors. especially with 
mouse b-opioid receptor (58.6%). Like other G protein- 
coupled receptors, potential N-glycosylation sites are 
seen at the NH,-terminal domain. A pair of cysteine 
residues proposed to form a disulfide bond occur in the 
first two extracellular loops. Compared to mouse 6- 
opioid receptor, consensus sequences for potential 
phosphorylation sites are almost conserved. These char- 
acteristics in the primary structure of pKOPR2 suggest 
that this clone encodes an opioid receptor. 
We next examined the binding of [3H]bremazocine to 
the membrane of COS-7 cells transfected with pcDNAI/ 
KOPR, which is a eukaryotic expression vector contain- 
ing the PstI-SpeI fragment of pKOPR2 as an insert, 
and found that the radioactive ligand bound specifically 
to the membrane with a dissociation constant (&) of 
0.37 nM. No binding was detected to the membrane of 
COS-7 cells transfected with pcDNAI/Amp. which is 
the vector without any insert (data not shown). As 
shown in Fig. 2, the binding of [3H]bremazocine was 
displaced by unlabeled opioid ligends, the displace- 
ment efficiency being dynorphin A (l- 
17) > U50488H >> DAMGO -L DPDPE. The Ic-selec- 
tive opioid ligands dynorphin A (1-17) and U50488H 
at 300 nM inhibited the binding by 85 and 33%, respec- 
tively. At the same concentration the p-selective ligand 
DAMGO and the &selective ligand DPDPE did not 
inhibit the binding at all. These results indicate that 
pKOPR2 encodes the K-opioid receptor. 
We observed that opioid receptors could link to 
phosphatidylinositol turnover and Ca2’ mobilization 
via inositol trisphosphate in Xenopus oocytes injected 
with poly(A)’ RNA derived from rat brain (unpub- 
lished data). The rise of intracellular Ca” can be 
detected as an inward current induced by opening of 
Ca’+- activated Cl- channel [lo]. Fig. 3 shows electro- 
physiological responses of a Xenopus oocyte injected 
with the mRNA transcribed in vitro with pKOPR2 as 
a template. The oocyte exhibited an inward current in 
response to 1 ,uM of U50488H. No response was evoked 
by DAMGO nor DPDPE at the same concentration. 
These results demonstrate that pKOPR2 encodes a 
functional n-opioid receptor. 
Fig. 4 compares the deduced amino acid sequences of 
rat Ic-opioid and mouse b-opioid receptors. As a whole 
the two sequences are 58.6% identical with each other. 
Especially, the putative transmembrane and intracellu- 
lar regions are 68.2% and 68.3% identical, respectively. 
Such high homology in the transmembrane and intra- 
cellular regions suggests that both receptors link to sim- 
ilar second messenger systems. On the other hand, 
lower homology (36.4%) is observed in extracellular 
regions which are thought to be involved in the ligand 
binding. The second extracellular loop of the rc-opioid 
receptor is rich in negatively charged amino acid resi- 
dues, compared to the d-type. This finding, together 
with the fact that dynorphin A. an endogenous Ic-opioid 
receptor ligand, has more arginine residues than any 
other endogenous opioid peptides, suggests that the sec- 
DAMGO DPDPE U-60488H 
-- I 
100 nA 
I 1 min 
Fig. 3. The current trace from the Xenopus oocyte inJected in vitro 
transcribed rat K-opiotd receptor mRNA. A downward deflectton 
indicates an inward current. Bars above the traces show the duration 
of application of each drug at 1 PM. 
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rKOPR 
mDOPR 
I 
MESPIQIFRGEPGPTCAPSACLLPNSSSWFPNWAESDSNGSLGSEDQQLEPAHISPAlPV 
** * *** ** * ** * * 
ME-------LVPSARAELQSSPLVNLSDAFPSAFPSAFPSAG~ASGS---PG~SASSL~AI 
60 
50 
rKOPR 
mDOPR 
II 
IITAVYSWFWGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSAVYL 
*** ** * *** ** **** * **** ***************** * * ***** ** 
AITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFN 
120 
110 
rKOPR 
mDOPR 
-UI 2 
MNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINI 
* **** *** * ************************************* *** *** 
METWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINI 
180 
170 
V 
rKOPR 
mDOPR 
CIWLLASSVGISAIVLGGTKVREDVDVIECSLQFPDDEYSW-WDLFMKICVFVFAFVIPV 
*** *** ** * * l * * * **** ** ** ***** **** * 
CIWVLASGVGVPIMVMAVTQPR-DGAV-VCMLQFP--SPSWYWDTVTKICVFLFAFWPI 
239 
226 
rKOPR 
mDOPR 
VI 
LIIIVCYTLMILRLKSVRLLSGSRE~RNLRRIT~~~AVFIICWTPIHIFIL~ 
*** *** ** *** ******** **** ***** ***** * ** ***** * * 
LIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLWVGAFWCWAPIHIFVIVWTL 
299 
286 
rKOPR 
mDOPR 
-XI 
-GSTSHSTAVLSSWFCIALGrPNSSLNPVLYAFLDENFKR 
* ****** ********************* * * * 
VDINRRDPLWAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLR 
351 
346 
rKOPR MERQSTNRVRNTVQDPASMRDVGGMNKPV 
** * * * * * * ** * 
RPRQATTRERVTACTP-SDGPGGGRAAP- 
380 
mDOPR 373 
Fig. 4. Compartson of the amino actd sequences of rat K-opiotd receptor (rKOPR) and mouse d-optoid receptor (mDOPR). The amino acid 
sequences of rat K-opioid (upper) and mouse &oploid (lower) receptor are aligned to achteve mawtmal homology. Asterisks Indicate exact matches 
between the two sequences, 
ond extracellular loop of this receptor is important to 
selective recognition of its ligands. 
Because pKOPR and pMOPR are highly homolo- 
gous to each other in the coding regions, 3’-noncoding 
region of pKOPR1 (nucleotides 1220-2371) was used as 
a template for synthesis of the 3’P-labeled antisense 
RNA probe. Upon northern blot analysis, all the re- 
gions of rat brain tested gave a single positive band at 
5.8 kilobases (Fig. 5). The difference in length between 
the band and the cloned cDNA is due to that we could 
not obtain full-length of 3’-noncoding region because of 
using random-priming method to construct a cDNA 
library and that poly A tail is usually added to 3’-end 
of mRNA in a eukaryotic cell. As can be seen in Fig. 
5, expression of K-opioid receptor mRNA was intensive 
in the striatum and hypothalamus, moderate in the thal- 
amus, midbrain and pons-medulla, and weak or slight 
in the cerebral cortex, hippocampus and cerebellum. 
This distribution pattern is consist with that of rc-opioid 
binding sites [l 11. A study of the detailed distribution 
of K-opioid receptor mRNA in rat brain is under way 
in our laboratory using an in situ hybridization tech- 
nique. 
In this study, we presented for the first time the clon- 
ing of the K-opioid receptor cDNA and its complete 
12345678 
- KOPR mRNA 
- 28s 
- 18s 
Fig. 5. Northern blot analysis of RNAs Isolated from various regions 
of rat bram. Four fig of poly(A)’ RNA was applied to each lane. Lane 
1, cerebral cortex; lane 2, hippocampus; lane 3. strtatum; lane 4, 
thalamus; lane 5, hypothalamus, lane 6. midbram: lane 7 pons-me- 
dulla; lane 8, cerebellum. 
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amino acid sequence. This work will be useful for mo- 
lecular studies on the functions of the opioid receptors 
through which endogenous opioid peptides and opiate 
drugs manifest their physiological and pharmacological 
effects. The expression and characterization of pMOPR 
are now in progress. 
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